Chris Finister, 52, from Evenley, will take part in the Bidwells Oxford 10k this Sunday, May 10, in support of his partner ...

Parents of children with Duchenne muscular dystrophy have spent the 17th night outside the government administration, ...

Today’s final draft guidance says givinostat (also called Duvyzat and made by ITF Pharma) can be used to treat Duchenne muscular dystrophy (DMD) in people aged 6 and over who are able to walk or stand ...

The most commonly diagnosed form of muscular dystrophy, Duchenne is a genetic disease that affects mostly boys and causes progressive muscle weakness over time. Its early physical signs tend to be ...

Initiation of Phase 3 IMPACT DUCHENNE placebo-controlled, randomized, double-blind trial as part of Solid’s integrated, multi-trial development ...

Georgia’s Health Ministry has expanded state-funded medical services for children with Duchenne Muscular Dystrophy and other ...

Exercise is an important component of care for children and adults with Duchenne muscular dystrophy (DMD). The many benefits include minimizing the progressive loss of muscle strength and maintaining ...

What’s been approved?: Givinostat, a drug for Duchenne muscular dystrophy, will be rolled out on the NHS to eligible children after a commercial agreement. Why it matters: The treatment can extend ...

Managing the transition to mobility aids is a pivotal part of life with DMD. Discover expert strategies for maintaining ...

Achieved the primary objective with favorable safety and tolerability, no discontinuations and no serious adverse events -- ...

While the company claimed a victory, analysts said data from a Phase 1/2 study fell short of expectations. Entrada shares ...

Orphan drug designation from the European Commission underscores Solid’s commitment to advance SGT-003 through a global development effort for ...